Definitive Contract 75F40121C00153

Georgia TECH Research Corp, the research arm of the Georgia Institute of Technology, received a $1.47M firm fixed-price definitive contract from the Food and Drug Administration under Broad Agency Announcement EETWP#45. The contract, awarded on September 30, 2020, with an ultimate completion date of September 29, 2023, focuses on identifying critical quality attributes of cell therapy products through multi-omics analyses and predictive modeling. This work supports the FDA's regulatory science...

The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order contract valued at ninety-six thousand nine hundred twenty-two dollars and eighty-five cents ($96,922.85) to Life Technologies Corporation. The contract is for the purchase of assurance preventative maintenance for an Applied Biosystems 3500XL genetic analyzer located in Atlanta, Georgia, and includes reinstatement fees for the base year plus four option years. Performance will take...

The Food and Drug Administration awarded a purchase order to Cell Microsystems Inc. for $52,550.00 on July 6, 2026, to procure a BioFlux 200+ flexible shear flow system under a Total Small Business set-aside. The equipment will be delivered to Durham, North Carolina and is intended for the FDA's Laboratory of Cellular Hematology to evaluate human platelets and red blood cells in physiological environments. The system must be new, capable of delivering shear flow rates from 0 to 200 dynes/cm²,...

The U.S. Food and Drug Administration (FDA) Office of Acquisition and Grants Services (OAGS) awarded a firm-fixed-price purchase order contract to Measurements Inc., a for-profit organization, for CDRH-2024-122027 Leakage Testing in Microfluidic Devices. The contract has a ceiling value of $29,486.00 and a completion date of July 4, 2025. The contract was not set aside for any specific business type. The contract originated from a solicitation posted on May 23, 2023, with a due date of June...

The Food and Drug Administration awarded a $1,085,530 definitive contract to Genentech Inc. on September 11, 2025, for advanced research and development in regulatory science addressing hybrid randomized controlled trials in longitudinal settings, with emphasis on causal methodologies for managing diverse missing data patterns. The contract was issued under a Fiscal Year 2025 Broad Agency Announcement for Advanced Research and Development of Regulatory Science, which solicited proposals across...

<p>The Food and Drug Administration issued a purchase order to Yokogawa Fluid Imaging Technologies, Inc. for a particle imaging analysis system on August 18, 2023, with a ceiling value of $100,309.00 and ultimate completion date of September 29, 2024. Work is performed in Newnan, Georgia. The order is firm fixed price with no set-aside designation.</p>

The Food and Drug Administration awarded a $247,126.75 firm fixed-price purchase order to Cytek Biosciences, Inc. for a multiparameter spectral analyzing flow cytometer. The contract, awarded on July 29, 2022, with an ultimate completion date of October 28, 2022, was issued without a set-aside designation. Performance of work will occur at Cytek Biosciences' facility in Fremont, California. The award resulted from a solicitation posted on May 20, 2022, with a due date of May 30, 2022. Cytek...

<p>This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Cellular Technology LIMITED, a self-certified small disadvantaged business. The contract, valued at $53,170.00, is for the purchase of DARS laboratory supplies and consumables. The contract has an ultimate completion date of August 31, 2026 and was awarded on August 12, 2025. The contract does not have a set-aside designation.</p>

The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order valued at $750,244.75 to Becton, Dickinson and Company BD Biosciences, Systems and Reagents Division for a Multiparameter Flow Cytometric Cell Sorter with Spectral Analysis and Cell Imaging (Imaging Cell Sorter). The equipment will be delivered to and utilized by the FDA's Center for Biologics Evaluation and Research facility in San Jose, California, under the terms of the order...

<p>The National Cancer Institute issued a delivery order to Becton, Dickinson and Company on September 17, 2019, for service maintenance of an LSRF Fortessa flow cytometer (S/N H17700008), with a ceiling value of $75,654.00.</p> <p>Place of performance is Bethesda, MD 20892. The order was firm fixed price with an ultimate completion date of September 16, 2020. The delivery order was issued under the GSA Schedule Scientific Equipment and Services (FSS-66), with no set-aside applied.</p>